Rays of Belief IPO Listing: Stock Lists at 1.67% Premium on BSE

Rays of Belief IPO Listing Shock: High Hopes Meet Market Reality

The domestic primary market witnessed a compelling debut as Rays of Belief Limited, a prominent healthcare and social enterprise specializing in neurodevelopmental care, made its entry. Despite commanding phenomenal enthusiasm during its bidding window—where the public issue was oversubscribed by a staggering 107.71 times—the stock’s post-listing trajectory delivered a sharp reality check to eager investors.

Muted Debut and Subsequent Listing Day Slump

Rays of Belief’s ₹125.00 crore initial public offering (IPO) was fixed at the upper band limit of ₹239 per share. Expectations were sky-high given the astronomical subscription numbers. However, the stock opened on a flat note on the National Stock Exchange (NSE) at ₹239.00 and registered a negligible nominal premium of roughly 1.5% on the Bombay Stock Exchange (BSE), debuting at ₹243.00.

The slight positive opening proved to be short-lived. Selling pressure quickly mounted as early investors and day traders rushed to book profits or cut exposure. The scrip drifted southward throughout the trading session, slipping to an intraday low of ₹228.00 on the BSE.

Despite a mild recovery from its lowest points, the stock managed to close at ₹228.25. For all the hype and stellar subscription figures, IPO allottees ended their maiden trading session staring at a net loss of approximately 4.50%, highlighting the growing disconnect between hyper-subscribed primary market valuations and immediate secondary market digestion.

Subscription Breakdown: A Wave of Bidding Frenzy

The sheer magnitude of the public response indicated massive retail and institutional appetite for niche, impact-driven healthcare stocks. Operating between September 1 and September 3, the ₹125.00 crore book-built issue consisted entirely of a fresh issue of 52.30 lakh equity shares with a face value of ₹10 each.

The category-wise subscription figures highlighted widespread participation across all investor segments:

• Qualified Institutional Buyers (QIBs): Subscribed 9.01 times (excluding anchor allocations).

• Non-Institutional Investors (NIIs): Witnessed heavy interest, subscribing 279.11 times.

• Retail Individual Investors (RIIs): Subscribed an overwhelming 195.86 times.

Ahead of the public launch, the company successfully mobilized ₹50 crore from anchor investors, signaling institutional confidence in its long-term business model.

Strategic Deployment of IPO Proceeds

Understanding where the capital goes is vital for assessing the company’s future trajectory. The net proceeds generated from the ₹125.00 crore public issue are designated for core expansion and operational scaling:

• Infrastructure & Centers: A major share (~₹26.88 crore) is allocated toward establishing new Company Learning Centers and centers tied up with licensed professionals.

• Specialized Facilities: Funds are directed toward School Collaboration Centers (₹5.54 crore), a dedicated Centre for Excellence and Research (₹2.45 crore), and an Upskilling Academy (₹2.05 crore).

• Technology & Leases: Investments will cover advanced technology hardware (₹4.44 crore) alongside structural lease payments for domestic and international centers.

• Inorganic Growth & Awareness: Part of the capital supports brand awareness campaigns, inclusive outreach programs, and potential future acquisitions.

Company Overview and Business Model

Headquartered out of Gurgaon (launching its first center in 2018), Rays of Belief operates primarily under the well-recognized brand name Mom’s Belief. It functions as a for-profit social enterprise delivering therapeutic, diagnostic, and developmental support for children suffering from neurodevelopmental disorders (NDDs).

Its clinical portfolio addresses conditions such as:

• Autism Spectrum Disorder (ASD)

• Attention Deficit Hyperactivity Disorder (ADHD)

• Down Syndrome and Cerebral Palsy

• Intellectual and Learning Disabilities

• Global Developmental Delay

Targeting children predominantly between 18 months and 12 years of age (with extended programs up to 15 years), the enterprise relies on an extensive catalog of over 150 physical teaching tools inside its centers, alongside home-learning kits featuring over 2,000 tools for parental guidance.

Rapid Footprint Expansion

The company has aggressively scaled its physical presence. From managing just 71 centers in fiscal 2023, its network expanded to 136 centers across 57 cities and 20 states/union territories by the end of March 2026. This footprint includes 42 centers in Tier-1 cities, 77 in Tier-2 cities, and 17 in Tier-3 markets, ensuring penetration into underserved semi-urban geographies. Furthermore, in June 2025, the company expanded internationally by acquiring Mom’s Belief US, Inc. as a wholly-owned subsidiary and Allergy & Immunology Virginia, LLC as a step-down subsidiary, securing three clinical centers in Salem, Lynchburg, and Roanoke, Virginia.

Financial Performance and Health

Rays of Belief showcases robust top-line acceleration, although near-term profitability reflects pressures from rapid expansion costs. Total income surged significantly, growing at a CAGR of over 63% to reach ₹82.06 crore. Meanwhile, net profits experienced short-term compression, closing at ₹4.96 crore.

On the balance sheet front, the company maintains a healthy financial cushion with reserves and surplus standing at ₹15.22 crore against a low total debt of ₹3.61 crore, giving it a comfortable debt-to-equity buffer as it executes its post-IPO expansion strategy.